MISEQDX Trademark

Trademark Overview

On Wednesday, February 12, 2014, a trademark application was filed for MISEQDX with the United States Patent and Trademark Office. The USPTO has given the MISEQDX trademark a serial number of 86191827. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, April 2, 2020. This trademark is owned by Illumina, Inc.. The MISEQDX trademark is filed in the Medical Instrument Products category with the following description:

Clinical and medical diagnostic instruments, namely nucleic acid sequencers
miseqdx

General Information

Serial Number86191827
Word MarkMISEQDX
Filing DateWednesday, February 12, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, April 2, 2020
Registration Number4601352
Registration DateTuesday, September 9, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 24, 2014

Trademark Statements

Pseudo MarkMI SEQ DX
Goods and ServicesClinical and medical diagnostic instruments, namely nucleic acid sequencers

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, February 25, 2014
Primary Code010
First Use Anywhere DateMonday, October 28, 2013
First Use In Commerce DateMonday, October 28, 2013

Trademark Owner History

Party NameIllumina, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
Party NameIllumina, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
Party NameIllumina, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events

Event DateEvent Description
Saturday, September 9, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, April 2, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, April 2, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 2, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 6, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, September 9, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 21, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 21, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 21, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 21, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 20, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 20, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 15, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 9, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, July 31, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 31, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 24, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 24, 2014PUBLISHED FOR OPPOSITION
Wednesday, June 4, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 16, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 16, 2014ASSIGNED TO EXAMINER
Wednesday, February 26, 2014NOTICE OF PSEUDO MARK E-MAILED
Tuesday, February 25, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 15, 2014NEW APPLICATION ENTERED

Related Keywords

miseqdx nucleic acid sequencers namely instruments medical diagnostic clinical